FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Governor DeSantis declares State of Emergency for Hurricane Ian
September 23, 2022

On Friday, September 23, 2022, Governor Ron DeSantis declared a State of Emergency to prepare for Hurricane Ian. Continue reading


Fourth Quarter Performance Report
September 2, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading